The number of people being admitted to hospital with Covid in England has begun to rise again, new data from the NHS shows. It comes as experts in Europe warned of a new wave of the virus driven by ...

High demand for lateral flow tests has resulted in supply issues, with many people unable to get their hands on the kits in recent days and pharmacies warning of “huge problems” with kit deliveries.

A Covid-19 lateral flow test showing a negative result. Routine testing to identify those infected followed by efficient contact tracing, and supported isolation is still the most effective public ...

Only a few years ago the benefits of lateral flow diagnostic tests weren’t widely understood outside of scientific circles. The reason most people came into contact with the technology was through the ...

The lateral flow assay market is poised for growth via increasing home-based self-testing kits, integration with smartphones for telehealth, and expansions in food safety and environmental monitoring.

Editor's Note: Article updated with latest information on availability of tests. People faced problems getting hold of the tests last week after a huge surge in demand prompted the Government website ...

Scientists and public health experts built the COVID-19 pandemic response on years of experience navigating infectious disease outbreaks. Although lateral flow immunoassays have been central to ...

As plan B measure are implemented across the UK, people are being urged to wear masks, work from home and take regular lateral flow tests. Lateral flow tests are for people who have no symptoms but ...

Before 2020, the words “lateral flow” meant little to anyone outside the scientific community. When talking to people unfamiliar with lateral flow, those working with the technology would often have ...

Lateral flow assays, also called immunochromatographic assays, identify or measure biomolecules in intricate samples like blood, saliva, urine, or other fluids to diagnose numerous medical conditions.

HENDERSON, Nev., July 8, 2025 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announces it has demonstrated quantification of ...

In a prospective, multicenter, adjudicator blinded clinical trial, Carl A. Deirmengian, MD, FAAOS, and colleagues conducted an alpha-defensin lateral-flow test for periprosthetic joint infection among ...